Compare Medpace Holdings Inc (MEDP) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs ABRDN Physical Gold Shares ETF — how do they compare? Medpace Holdings Inc trades at $532.42 (market cap $15.08B), while ABRDN Physical Gold Shares ETF trades at $38.89. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | SGOL | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $620.59 | $51.41 |
52-Week Low | $308.88 | $31.18 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
SGOL is trading at $38.16, down 0.16% with a bearish technical outlook indicated by 16 sell signals against 0 buy signals. The stock faces pressure from higher interest rate expectations and dollar strength, though central bank gold buying provides structural support. Recent trading has tested key support levels around $38 with resistance forming at $39.
The outlook remains cautious with technical indicators signaling bearish momentum and fundamental data limited. Investment opportunities exist for long-term gold exposure, but risks include Fed policy uncertainty and dollar volatility. Near-term direction depends on gold's ability to hold $4,000/oz support amid competing macroeconomic forces.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
